CT of renal cell carcinoma: assessment of collecting system invasion - Abstract

OBJECTIVE: Although renal collecting system invasion is not considered in the current TNM staging system, this finding may be relevant in terms of treatment planning and prognosis. The objective of this study was to investigate the frequency of collecting system invasion in renal cell carcinoma (RCC) and to assess the diagnostic performance of excretory phase CT for the assessment of collecting system invasion.

MATERIALS AND METHODS: We conducted a retrospective study of 261 patients (171 men and 90 women; average age, 61 years; age range, 32-86 years) who underwent CT before nephrectomy for RCC between November 2008 and July 2011 at a single institution. On excretory phase contrast-enhanced CT images, two radiologists independently determined whether RCC components caused a filling defect within the collecting system and whether the RCC was in contact to the collecting system wall or separated from it. Histopathology served as the standard of reference. Interreader agreement and diagnostic performance tests for the detection of collecting system invasion were calculated.

RESULTS: Histopathology identified collecting system invasion exclusively in clear cell RCC that showed a filling defect within the collecting system on excretory phase CT images (5.4%, 14/261). Tumors separated from or in contact with the collecting system on imaging (both readers; 94.6%, 247/261) did not show collecting system invasion on histopathology (sensitivity, 100%; specificity, 100%). Interreader agreement was excellent (κ, 0.965; 95% CI, 0.93-0.99).

CONCLUSION: CT provides reliable assessment of collecting system invasion in patients with RCC, with excellent sensitivity and specificity.

Written by:
Karlo CA, Di Paolo PL, Hricak H, Tickoo SK, Russo P, Akin O   Are you the author?
1 Department of Radiology, Memorial Sloan-Kettering Cancer Center, Radiology Academic Offices, Rm C278, 1275 York Ave, New York, NY 10065

Reference: AJR Am J Roentgenol. 2013 Dec;201(6):W821-7
doi: 10.2214/AJR.13.10785


PubMed Abstract
PMID: 24261389

UroToday.com Renal Cancer Section